Oral Sessions (Day1, Day2, Day3)
Poster Presentations
(Day1, Day2, Day3)
Oral Sessions
- Day 1, May 15（Wed.） 14:45-15:25 Room C (101)
-
1C-O1-1445 PDF
Current Status and Issues of New Drug Modality Quantification by LC/MS
The trend in drug discovery and development is shifting towards biologics because of the decrease in productivity for small-molecule drug development. Therapeutic antibodies already have the largest market share in the current biopharmaceutical. Recently the therapeutic potential of new drug modalities such as peptide-based drugs, oligonucleotides and cell therapy is increasingly recognized and their development is aggressively conducted. LC/MS plays an important role in these fields, however, there remains various practical issues regarding quantification of targets. Therefore future technological innovation is highly needed even now.